Aclaris Therapeutics Inc (ACRS)

17.99 +0.18  +1.01% NASDAQ Jun 16, 16:59 USD

Aclaris Therapeutics Cash from Investing (TTM):

-82.87M for March 31, 2021
View 4,000+ financial data types
View Full Chart

Cash from Investing (TTM) Chart

Export Data
Save Image
Print Image

Historical Cash from Investing (TTM) Data

View and export this data going back to 2015. Start your Free Trial
Export Data Date Range:
Data for this Date Range  
March 31, 2021 -82.87M
Dec. 31, 2020 6.387M
Sept. 30, 2020 65.13M
June 30, 2020 81.57M
March 31, 2020 111.00M
Dec. 31, 2019 105.68M
Sept. 30, 2019 -21.26M
June 30, 2019 -32.54M
March 31, 2019 -38.21M
Dec. 31, 2018 9.367M
Sept. 30, 2018 58.31M
June 30, 2018 8.057M
March 31, 2018 -5.455M
Dec. 31, 2017 -55.69M
Sept. 30, 2017 -111.94M
June 30, 2017 -76.22M
March 31, 2017 -66.12M
Dec. 31, 2016 -61.90M
Sept. 30, 2016 -53.57M
June 30, 2016 -62.56M
March 31, 2016 -67.52M
Dec. 31, 2015 -76.95M

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.


Cash From Investing Definition

Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.

Read full definition.

Cash from Investing (TTM) Benchmarks

Ocugen Inc -0.5148M
GBS Inc -0.014M
Precipio Inc -0.257M

Cash from Investing (TTM) Range, Past 5 Years

Minimum -111.94M Sep 2017
Maximum 111.00M Mar 2020
Average -11.14M


Top Biotech Stocks for Q3 2021
Yahoo 06/08 15:16 ET



Please note that this feature is only available as an add-on to YCharts subscriptions.

Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{}} No credit card required.

Already a subscriber? Sign in.